Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Knight Therapeutics Inc
T.GUD
Alternate Symbol(s):
KHTRF
Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select...
international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:GUD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Nov 24, 2022 6:31am
RE:RE:RE:RE:RE:RE:RE:RE:RE:Impacted by end of agrements in LATAM- is this only Gilead ?
Boring beyond death. now in ER
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Nov 23, 2022 4:47pm
RE:RE:RE:RE:RE:RE:RE:RE:Impacted by end of agrements in LATAM- is this only Gilead ?
Agreed - always said it was a boring company and it will be ... until it isn't anymore. Also said it will move sideways until it doesn't anymore ... took 12 years to start moving as PLB
...more
NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets
posted Nov 14, 2024 9:00am by
NurExone Biologic Inc.
-
|
“We are honored by the EMA’s recognition of ExoPTEN through the Orphan Medicinal Product Designation, which significantly advances our ability to enter the European market and offers hope to those impacted by acute spinal cord injuries,” said Dr. Lior Shaltiel, Chief Executive Officer of NurExone. “This designation, together with the ...read more
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Comment by
gudisgood
on Nov 23, 2022 5:54am
RE:Something new
Do I remember wrong, or did some of those BGx expected launches move 2024 -> 2025?
(8)
•••
wofats
X
View Profile
View Bullboard History
Post by
wofats
on Nov 22, 2022 3:44pm
Something new
https://www.gud-knight.com/wp-content/uploads/GUD-Investor-presentation_November-2022.pdf
(5)
•••
Snowballgrowth
X
View Profile
View Bullboard History
Comment by
Snowballgrowth
on Nov 19, 2022 7:40am
RE:RE:Impacted by end of agrements in LATAM- is this only Gilead ?
Thank you for your response. A very good one !
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Nov 18, 2022 3:22pm
Multiplier effect
Now GUD has a Massive distribution arm built in 8 years or 6.5 since completion of GBT acquisition -now get to see the multiplier effect of the first drug take place and then repeat.
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Nov 18, 2022 2:20pm
How many years has it been ?
Since he asked.
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Nov 18, 2022 12:48pm
How many years did Goodman ask for?
At the outset of Knight to build the foundation.
(4)
•••
russter
X
View Profile
View Bullboard History
Comment by
russter
on Nov 17, 2022 4:26pm
RE:RE:RE:RE:RE:RE:RE:Impacted by end of agrements in LATAM- is this only Gilead ?
Good for you CC, making it a mission keeping Mugsy in line. I get a good laugh from both of you guys? Alas you are right though GUD is probably the most boring sock on the TSX. And the USLESS
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Nov 13, 2022 1:00pm
RE:RE:RE:RE:RE:Impacted by end of agrements in LATAM- is this only Gilead ?
Absolutely - this is exactly how Samira/Goodman build a powerhouse in ROW. Selling in LATAM will always be evaluated and new strategies set if need be. Where to take Exelon will be discussed - rights
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Nov 12, 2022 5:05pm
RE:RE:RE:RE:RE:Impacted by end of agrements in LATAM- is this only Gilead ?
I totally agree the plan is to keep losing fortunes on generics, latam and argentina with inflation rate "oficlaly" 85% reality 200%. Time to turf MNT and BDO out. Meir knew better
...more
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Comment by
gudisgood
on Nov 12, 2022 11:25am
RE:RE:RE:Impacted by end of agrements in LATAM- is this only Gilead ?
Good point! :)
(6)
•••
curiousj
X
View Profile
View Bullboard History
Comment by
curiousj
on Nov 12, 2022 11:12am
RE:RE:Impacted by end of agrements in LATAM- is this only Gilead ?
$6mn of OCF is due to settlement with GBT , equivalent to 50% of OCF for q3
(6)
•••
curiousj
X
View Profile
View Bullboard History
Comment by
curiousj
on Nov 12, 2022 11:05am
RE:RE:RE:RE:Impacted by end of agrements in LATAM- is this only Gilead ?
keep in mind that Exelon is a branded generic and the focus with the new head of branded generics at Knight will be to right size the business and refocus on the right categories and brands... also
...more
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Explained: The Psychology of Options Trading with Practical Tips
Meet the Top 5 Best Online Brokerages in Canada
New Gold and Copper Hotspot Identified – What’s Next for This Serbian Project?
Major Funding Secured! Company Closes First Round of Private Placement
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023
Gold, growth and sustainability in focus for this resource company
Star Diamond Corporation Announces Third Quarter 2024 Results
This $10M Deal Could Reshape the Future of Global Creator Platforms
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits